English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In view of the increased incidence of thromboembolism in users of oral contraceptives the study measured alpha-macroglobulin which decreases the fibrinolytic activity of plasmin in vitro and cryofibrinogen which indicates incomplete intravascular proteolysis of fibrinogen to fibrin. 20 women gave blood samples before therapy after 12 weeks of oral contraception and 12 weeks after stopping the pill. Serum IgG and alpha-macroglobulin were determined by immunodiffusion and the results expressed as a percentage of the World Health Organization Reference Standard. IgG was 137% (geometric mean) of W.H.O. standard before pills 188% (mean) during pill use and 168% (mean) 12 weeks after. Alpha-macroglobulin was 124% (geometric mean) before 210% (mean) during and 172% (mean) 12 weeks after the pill. Incidence of cryofibrinogen was 5% (geometric mean) before 30% (mean) during and 15% (mean) 12 weeks after the pill. These differences were significant at p greater than .01 during pill intake and at p greater than .05 12 weeks after stopping the pill.

SERUM LEVELS OF IgG AND -MACROGLOBULIN AND INCIDENCE OF CRYOFIBRINOGENAEMIA IN WOMEN TAKING ORAL CONTRACEPTIVES